Clinical Trials Logo

Multivessel Coronary Disease clinical trials

View clinical trials related to Multivessel Coronary Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05231226 Not yet recruiting - Clinical trials for ST-elevation Myocardial Infarction

Timing of Complete Revascularization in Patients With ST-segment Elevation Myocardial Infarction And Multivessel Disease

TERMINAL
Start date: March 2022
Phase: N/A
Study type: Interventional

At present, the two treatment strategies of opening non infarct related arteries (non IRA) simultaneously or by stages after emergency percutaneous coronary intervention (PCI) in patients with acute ST segment elevation myocardial infarction (STEMI) complicated with multi vessel disease (MVD) are still controversial. In our previous retrospective analysis, there was no significant difference between complete revascularization (CR) and staged CR at Anzhen Hospital in the cases of cardiac death, reinfarction, stroke, proportion of revascularization and hospitalization rate of heart failure.

NCT ID: NCT03135275 Completed - Clinical trials for ST-elevation Myocardial Infarction

MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial

MULTISTARS AMI
Start date: October 2016
Phase: N/A
Study type: Interventional

The primary objective of the trial is to compare, in patients presenting with ST segment elevation myocardial infarction (STEMI) and multi-vessel disease (MVD), the safety and efficacy of immediate complete revascularization of all significant coronary lesions versus culprit vessel only revascularization and staged percutaneous coronary intervention (PCI) of all significant coronary lesions (within 19 to 45 days), in a non-inferiority trial using a third generation, biodegradable-polymer, everolimus-eluting stent.